Interoceptive Training Enhanced Mindfulness

NCT ID: NCT06786572

Last Updated: 2025-11-10

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

48 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-09-10

Study Completion Date

2027-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This pilot randomized controlled trial will compare a novel mindfulness training to interoceptive exposure to establish feasibility and acceptability as an intervention for anxiety sensitivity.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Anxiety sensitivity (AS), which involves fear that arousal related symptoms will have negative physical, social or psychological ramifications, is an important driver of anxiety, trauma-related and somatic disorders. Cognitive behavioral therapy (CBT), particularly involving interoceptive exposure (IE; i.e., exposure to unwanted internal sensations), has the greatest demonstrated efficacy at reducing AS but can be hard to tolerate. Conversely, mindfulness is sought out for management of multiple mental health problems, but the observed clinical effects are often modest. A hybrid of these two approaches may capitalize on the strengths of each approach. Mindfulness training (MT) may increase the tolerability of exposure, enhance compliance and support extinction learning through increased engagement with the feared stimulus and heightened awareness of the nonoccurrence of feared outcomes. This project will evaluate the feasibility and acceptability of a novel hybrid intervention, Interoceptive Training Enhanced Mindfulness (ITEM), which combines IE with MT, evaluate its feasibility and acceptability. Forty-eight Veterans will be randomized to receive ITEM or IE in six one-on-one sessions delivered via telehealth. They will complete assessments before and after the 6-week intervention period. Outcomes related to engagement and compliance with ITEM and IE will be the primary focus. Because multiple mental health (e.g., anxiety, posttraumatic stress disorder, eating disorders and depression) and physical health (e.g., chronic pain, conditions related to toxic exposure) problems are driven by maladaptive reactions to interoceptive cues, this intervention has the potential to ultimately produce wide-spread mental and physical health benefits.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Anxiety Sensitivity

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

anxiety sensitivity mindfulness interoception

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

OTHER

Blinding Strategy

SINGLE

Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Interoceptive Training Enhanced Mindfulness (ITEM)

Brief mindfulness training focused on management of unwanted internal sensations

Group Type EXPERIMENTAL

Mindfulness training

Intervention Type OTHER

Brief mindfulness training focused on management of unwanted internal sensations

Interoceptive Exposure (IE)

Cognitive behavioral intervention featuring systematic exposure to unwanted internal sensations

Group Type ACTIVE_COMPARATOR

Interoceptive exposure

Intervention Type BEHAVIORAL

Cognitive behavioral therapy focused in interoceptive exposure to unwanted internal sensations

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Mindfulness training

Brief mindfulness training focused on management of unwanted internal sensations

Intervention Type OTHER

Interoceptive exposure

Cognitive behavioral therapy focused in interoceptive exposure to unwanted internal sensations

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Veteran status
* able to read and speak English
* ASI-3 score of 23 or higher
* clinically meaningful distress/impairment related to an emotional or somatic complaint as determined by a Clinical Global Impression Scale (CGI) of 3 or greater
* Internet access via a device that can support remote study activities and ability to attend in person appointments

Exclusion Criteria

* serious mental illness, including bipolar disorder or psychotic illness
* current, untreated alcohol or substance use disorder
* moderate-severe suicidality that would likely result in the need for urgent intervention in the next 2 months
* current regular meditation practice or treatment for AS-related condition
* cognitive dysfunction that interferes with the ability to engage in treatment
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

National Center for Complementary and Integrative Health (NCCIH)

NIH

Sponsor Role collaborator

Veterans Medical Research Foundation

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

VA San Diego Healthcare System

San Diego, California, United States

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

United States

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Ariel J Lang, PhD, MPH

Role: CONTACT

Phone: 8585528585

Email: [email protected]

Jafer Vazquez Alcaraz

Role: CONTACT

Phone: 858-367-0243

Email: [email protected]

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Niloofar Afari

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

1R34AT012499-01A1

Identifier Type: NIH

Identifier Source: secondary_id

View Link

H230149

Identifier Type: -

Identifier Source: org_study_id